Feifan Xiao

1.8k total citations · 1 hit paper
43 papers, 1.1k citations indexed

About

Feifan Xiao is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feifan Xiao has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feifan Xiao's work include Metabolism and Genetic Disorders (6 papers), Genomics and Rare Diseases (5 papers) and COVID-19 Impact on Reproduction (4 papers). Feifan Xiao is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Genomics and Rare Diseases (5 papers) and COVID-19 Impact on Reproduction (4 papers). Feifan Xiao collaborates with scholars based in China and Canada. Feifan Xiao's co-authors include Wenhao Zhou, Kai Yan, Wenhao Yuan, Jianbo Shao, Lingkong Zeng, Shiwen Xia, Xiaoli Yang, Lin Yang, Bingbing Wu and Chengdong Zhang and has published in prestigious journals such as Gene, Oncotarget and JAMA Network Open.

In The Last Decade

Feifan Xiao

41 papers receiving 1.1k citations

Hit Papers

Neonatal Early-Onset Infe... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifan Xiao China 12 640 321 232 215 146 43 1.1k
Lingkong Zeng China 9 860 1.3× 373 1.2× 280 1.2× 259 1.2× 139 1.0× 25 1.1k
Junli Fan China 12 509 0.8× 228 0.7× 711 3.1× 138 0.6× 104 0.7× 20 1.5k
Xingguang Lin China 12 575 0.9× 264 0.8× 131 0.6× 246 1.1× 43 0.3× 27 971
Alexandre Vivanti France 17 1.3k 2.0× 529 1.6× 326 1.4× 545 2.5× 113 0.8× 68 1.7k
Kristen Thomas United States 15 364 0.6× 134 0.4× 139 0.6× 107 0.5× 265 1.8× 37 977
Reza Bahrami Iran 11 312 0.5× 170 0.5× 113 0.5× 152 0.7× 86 0.6× 73 675
Elizabeth Wastnedge United Kingdom 8 323 0.5× 165 0.5× 101 0.4× 241 1.1× 152 1.0× 11 936
A. Seval Özgü-Erdinç Türkiye 16 640 1.0× 348 1.1× 58 0.3× 276 1.3× 39 0.3× 96 1.0k
Min Wei China 14 330 0.5× 80 0.2× 392 1.7× 69 0.3× 78 0.5× 39 950
Cassandra E. Henderson United States 19 365 0.6× 300 0.9× 134 0.6× 334 1.6× 56 0.4× 66 984

Countries citing papers authored by Feifan Xiao

Since Specialization
Citations

This map shows the geographic impact of Feifan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifan Xiao more than expected).

Fields of papers citing papers by Feifan Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifan Xiao. The network helps show where Feifan Xiao may publish in the future.

Co-authorship network of co-authors of Feifan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Feifan Xiao. A scholar is included among the top collaborators of Feifan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifan Xiao. Feifan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qiong, Yulan Lu, Bo Liu, et al.. (2025). Deep clinical and genetic analysis of 17p13.3 region: 38 pediatric patients diagnosed using next-generation sequencing and literature review. BMC Medical Genomics. 18(1). 90–90. 1 indexed citations
2.
Yang, Lin, et al.. (2024). Genotype and phenotype features and prognostic factors of neonatal-onset pyridoxine-dependent epilepsy: A systematic review. Epilepsy Research. 202. 107363–107363. 5 indexed citations
3.
Yan, Kai, Feifan Xiao, Peng Zhang, et al.. (2024). Brain development in newborns and infants after ECMO. World Journal of Pediatrics. 20(6). 556–568. 11 indexed citations
4.
Sun, Weihua, Yi Wang, Hongjiang Wu, et al.. (2023). Fourteen cases of cerebral creatine deficiency syndrome in children: a cohort study in China. Translational Pediatrics. 12(5). 927–937. 2 indexed citations
5.
Xiao, Feifan, Meiling Tang, Kai Yan, & Wenhao Zhou. (2022). Clinical features of infants with SARS-CoV-2 infection: a systematic review and meta-analysis. Annals of Palliative Medicine. 11(11). 3394–3408. 4 indexed citations
6.
Ni, Qi, Xiang Chen, Ping Zhang, et al.. (2022). Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to Caucasians. Orphanet Journal of Rare Diseases. 17(1). 129–129. 20 indexed citations
7.
Gan, Mingyu, Kai Yan, Feifan Xiao, et al.. (2021). Combining Metagenomic Sequencing With Whole Exome Sequencing to Optimize Clinical Strategies in Neonates With a Suspected Central Nervous System Infection. Frontiers in Cellular and Infection Microbiology. 11. 671109–671109. 29 indexed citations
8.
Zeng, Lingkong, Huaping Zhu, Tiantian Xiao, et al.. (2021). Short-term developmental outcomes in neonates born to mothers with COVID-19 from Wuhan, China. World Journal of Pediatrics. 17(3). 253–262. 11 indexed citations
9.
Wang, Jinhui, Tiantian Xiao, Feifan Xiao, et al.. (2021). Time Distributions of Common Respiratory Pathogens Under the Spread of SARS-CoV-2 Among Children in Xiamen, China. Frontiers in Pediatrics. 9. 584874–584874. 7 indexed citations
10.
Yan, Kai, Feifan Xiao, Yuwei Jiang, et al.. (2021). Effects of SARS-CoV-2 infection on neuroimaging and neurobehavior in neonates. World Journal of Pediatrics. 17(2). 171–179. 9 indexed citations
11.
Xiao, Feifan, Kai Yan, Huijun Wang, et al.. (2021). Protocol of the China Neonatal Genomes Project: an observational study about genetic testing on 100,000 neonates. 4. 28–28. 8 indexed citations
12.
Liu, Bo, Bingbing Wu, Yi Lu, et al.. (2020). A Novel, Recurrent, 3.6-kb Deletion in the PYGL Gene Contributes to Glycogen Storage Disease Type VI. Journal of Molecular Diagnostics. 22(12). 1373–1382. 4 indexed citations
13.
Xiao, Feifan, Bin Chen, Tiantian Xiao, et al.. (2020). Children with SARS-CoV-2 infection during an epidemic in China (outside of Hubei province). Annals of Translational Medicine. 8(14). 849–849. 9 indexed citations
14.
Xiao, Feifan, Kai Yan, & Wenhao Zhou. (2019). Methadone versus morphine treatment outcomes in neonatal abstinence syndrome: A meta‐analysis. Journal of Paediatrics and Child Health. 55(10). 1177–1182. 6 indexed citations
15.
Zhao, Dong, Jiatong Li, Feifan Xiao, et al.. (2017). Association between F508 deletion in CFTR and chronic pancreatitis risk. Digestive and Liver Disease. 49(9). 967–972. 3 indexed citations
16.
Xiao, Feifan, Jian Pu, Yuening Zhang, et al.. (2017). Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget. 8(29). 48488–48506. 20 indexed citations
17.
Yu, Kaihui, Ruoheng Zhang, Jiatong Li, et al.. (2016). The HLA-DRB1 allele polymorphisms and nasopharyngeal carcinoma. Tumor Biology. 37(6). 7119–7128. 8 indexed citations
18.
Li, Jiatong, Feifan Xiao, Yuening Zhang, et al.. (2016). Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer. Technology in Cancer Research & Treatment. 16(2). 159–166. 8 indexed citations
19.
Xiao, Feifan, Shaoming Lu, Jingyu Song, et al.. (2016). Research trends and perspectives of male infertility: a bibliometric analysis of 20 years of scientific literature. Andrology. 4(6). 990–1001. 30 indexed citations
20.
Lin, Li-Yan, et al.. (2015). Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis. Genetics and Molecular Research. 14(2). 6256–6264. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026